C. Rouzer and L. Marnett, Cyclooxygenases: structural and functional insights, The Journal of Lipid Research, vol.50, issue.Supplement, pp.29-34, 2009.
DOI : 10.1194/jlr.R800042-JLR200
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2674713

R. Medzhitov, Inflammation 2010: New Adventures of an Old Flame, Cell, vol.140, issue.6, pp.771-776
DOI : 10.1016/j.cell.2010.03.006

J. Geng, Directional migration of leukocytes: their pathological roles in inflammation and strategies for development of anti-inflammatory therapies, Cell Research, vol.107, issue.2, pp.85-88, 2001.
DOI : 10.1006/smim.2000.0210

J. Bayry, N. Misra, V. Latry, F. Prost, and S. Delignat, Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases, Transfusion Clinique et Biologique, vol.10, issue.3, pp.165-169, 2003.
DOI : 10.1016/S1246-7820(03)00035-1

J. Bayry and V. Negi, Intravenous immunoglobulin therapy in rheumatic diseases, Nature Reviews Rheumatology, vol.124, issue.6, pp.349-359
DOI : 10.1038/nrrheum.2011.61

P. Rao and E. Knaus, Evolution of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Cyclooxygenase (COX) Inhibition and Beyond, Journal of Pharmacy & Pharmaceutical Sciences, vol.11, issue.2, pp.81-110, 2008.
DOI : 10.18433/J3T886

C. Sharma, J. Kaur, S. Shishodia, B. Aggarwal, and R. Ralhan, Curcumin down regulates smokeless tobacco-induced NF-??B activation and COX-2 expression in human oral premalignant and cancer cells, Toxicology, vol.228, issue.1, pp.1-15, 2006.
DOI : 10.1016/j.tox.2006.07.027

J. Jurenka, Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research, Altern Med Rev, vol.14, pp.141-153, 2009.

K. Cullberg, J. Olholm, S. Paulsen, C. Foldager, and M. Lind, Resveratrol has inhibitory effects on the hypoxia-induced inflammation and angiogenesis in human adipose tissue in vitro, European Journal of Pharmaceutical Sciences, vol.49, issue.2, pp.251-257
DOI : 10.1016/j.ejps.2013.02.014

T. Ismail, P. Sestili, and S. Akhtar, Pomegranate peel and fruit extracts: A review of potential anti-inflammatory and anti-infective effects, Journal of Ethnopharmacology, vol.143, issue.2, pp.397-405
DOI : 10.1016/j.jep.2012.07.004

L. Parente, L. J. Rde, S. Tresvenzol, L. Vinaud, M. De-paula et al., Wound Healing and Anti-Inflammatory Effect in Animal Models of Calendula officinalis L. Growing in Brazil, p.375671

Y. Sreenivasan, A. Sarkar, and S. Manna, Oleandrin suppresses activation of nuclear transcription factor-??B and activator protein-1 and potentiates apoptosis induced by ceramide, Biochemical Pharmacology, vol.66, issue.11, pp.2223-2239, 2003.
DOI : 10.1016/j.bcp.2003.07.010

K. Urech, G. Schaller, and C. Jaggy, Viscotoxins, Mistletoe Lectins and their Isoforms in Mistletoe (Viscum album L.) Extracts Iscador, Arzneimittelforschung, vol.56, issue.06, pp.428-434, 2006.
DOI : 10.1055/s-0031-1296808

S. Olsnes, F. Stirpe, K. Sandvig, and A. Pihl, Isolation and characterization of viscumin, a toxic lectin from Viscum album L. (mistletoe), J Biol Chem, vol.257, pp.13263-13270, 1982.

T. Hajto, K. Hostanska, and H. Gabius, Modulatory potency of the beta-galactosidespecific lectin from mistletoe extract (Iscador) on the host defense system in vivo in rabbits and patients, Cancer Res, vol.49, pp.4803-4808, 1989.

H. Bantel, I. Engels, W. Voelter, K. Schulze-osthoff, and S. Wesselborg, Mistletoe lectin activates caspase-8/FLICE independently of death receptor signaling and enhances anticancer drug-induced apoptosis, Cancer Res, vol.59, pp.2083-2090, 1999.

Y. Surh, K. Chun, H. Cha, S. Han, and Y. Keum, Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-??B activation, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol.480, issue.481, pp.480-481, 2001.
DOI : 10.1016/S0027-5107(01)00183-X

Y. Surh, Anti-tumor promoting potential of selected spice ingredients with antioxidative and anti-inflammatory activities: a short review, Food and Chemical Toxicology, vol.40, issue.8, pp.1091-1097, 2002.
DOI : 10.1016/S0278-6915(02)00037-6

D. Zhang, J. Wu, F. Ye, L. Xue, and S. Jiang, Inhibition of cancer cell proliferation and prostaglandin E2 synthesis by Scutellaria baicalensis, Cancer Res, vol.63, pp.4037-4043, 2003.

W. Liu and D. Fowler, Cannabis-Derived Substances in Cancer Therapy ??? An Emerging Anti-Inflammatory Role for the Cannabinoids, Current Clinical Pharmacology, vol.5, issue.4, pp.281-287
DOI : 10.2174/157488410793352049

E. Kim, J. Min, T. Kim, S. Lee, and H. Yang, [6]-Gingerol, a pungent ingredient of ginger, inhibits angiogenesis in vitro and in vivo, Biochemical and Biophysical Research Communications, vol.335, issue.2, pp.300-308, 2005.
DOI : 10.1016/j.bbrc.2005.07.076

P. Hegde, M. Maddur, A. Friboulet, J. Bayry, and S. Kaveri, Viscum album Exerts Anti-Inflammatory Effect by Selectively Inhibiting Cytokine-Induced Expression of Cyclooxygenase-2, PLoS ONE, vol.35, issue.10, p.26312
DOI : 10.1371/journal.pone.0026312.t001
URL : https://hal.archives-ouvertes.fr/hal-00637405

C. Yang, T. Or, and M. Ho, Scientific Basis of Botanical Medicine as Alternative Remedies for Rheumatoid Arthritis, Clinical Reviews in Allergy & Immunology, vol.54, issue.3, pp.284-300
DOI : 10.1007/s12016-012-8329-8

I. Ciris, K. Bozkurt, S. Baspinar, and F. Kapucuoglu, Immunohistochemical COX-2 overexpression correlates with HER-2/neu overexpression in invasive breast carcinomas: A pilot study, Pathology - Research and Practice, vol.207, issue.3, pp.182-187
DOI : 10.1016/j.prp.2011.01.005

L. Crofford, COX-2 in synovial tissues, Osteoarthritis and Cartilage, vol.7, issue.4, pp.406-408, 1999.
DOI : 10.1053/joca.1999.0226

T. Samad, K. Moore, A. Sapirstein, S. Billet, and A. Allchorne, Interleukin- 1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity, Nature, vol.410, issue.6827, pp.471-475, 2001.
DOI : 10.1038/35068566

G. Fitzgerald, COX-2 and beyond: approaches to prostaglandin inhibition in human disease, Nature Reviews Drug Discovery, vol.5, issue.11, pp.879-890, 2003.
DOI : 10.1038/384644a0

K. Chun and Y. Surh, Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention, Biochemical Pharmacology, vol.68, issue.6, pp.1089-1100, 2004.
DOI : 10.1016/j.bcp.2004.05.031

K. Seibert, Y. Zhang, K. Leahy, S. Hauser, and J. Masferrer, Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain., Proceedings of the National Academy of Sciences, vol.91, issue.25, pp.12013-12017, 1994.
DOI : 10.1073/pnas.91.25.12013

J. Linder, K. Monkemuller, J. Davis, and C. Wilcox, Cyclooxygenase-2 inhibitor celecoxib: a possible cause of gastropathy and hypoprothrombinemia, South Med J, vol.93, pp.930-932, 2000.

C. Hawkey, Nonsteroidal anti-inflammatory drug gastropathy, Gastroenterology, vol.119, issue.2, pp.521-535, 2000.
DOI : 10.1053/gast.2000.9561

H. Davenport, Salicylate Damage to the Gastric Mucosal Barrier, New England Journal of Medicine, vol.276, issue.23, pp.1307-1312, 1967.
DOI : 10.1056/NEJM196706082762308

F. Buttgereit, G. Burmester, and L. Simon, Gastrointestinal toxic side effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2???specific inhibitors, The American Journal of Medicine, vol.110, issue.3, pp.13-19, 2001.
DOI : 10.1016/S0002-9343(00)00728-2

M. Stubanus, G. Riegger, M. Kammerl, M. Fischereder, and B. Kramer, Renal side-effects of cyclo-oxygenase-type-2 inhibitor use, The Lancet, vol.355, issue.9205, p.753, 2000.
DOI : 10.1016/S0140-6736(05)72163-2

D. Van-huyen, J. Delignat, S. Kazatchkine, M. Kaveri, and S. , Comparative Study of the Sensitivity of Lymphoblastoid and Transformed Monocytic Cell Lines to the Cytotoxic Effects of Viscum album Extracts of Different Origin, Chemotherapy, vol.49, issue.6, pp.298-302, 2003.
DOI : 10.1159/000074530

P. Escher, M. Eiblmeier, I. Hetzger, and H. Rennenberg, Spatial and seasonal variation in amino compounds in the xylem sap of a mistletoe (Viscum album) and its hosts (Populus spp. and Abies alba), Tree Physiology, vol.24, issue.6, pp.639-650, 2004.
DOI : 10.1093/treephys/24.6.639

P. Escher, M. Eiblmeier, I. Hetzger, and H. Rennenberg, Seasonal and spatial variation of carbohydrates in mistletoes (Viscum album) and the xylem sap of its hosts (Populus x euamericana and Abies alba), Physiologia Plantarum, vol.32, issue.2, pp.212-219, 2004.
DOI : 10.1146/annurev.arplant.41.1.127

E. Wollenweber, A. Wieland, and K. Haas, Epicuticular waxes and flavonol aglycones of the European mistletoe, Viscum album L, Z Naturforsch C, vol.55, pp.314-317, 2000.

A. Bussing and M. Schietzel, Apoptosis-inducing properties of Viscum album L. extracts from different host trees, correlate with their content of toxic mistletoe lectins, Anticancer Res, vol.19, pp.23-28, 1999.

A. Bussing, K. Suzart, J. Bergmann, U. Pfuller, and M. Schietzel, Induction of apoptosis in human lymphocytes treated with Viscum album L. is mediated by the mistletoe lectins, Cancer Letters, vol.99, issue.1, pp.59-72, 1996.
DOI : 10.1016/0304-3835(95)04038-2

K. Rainsford, Anti-Inflammatory Drugs in the 21st Century, Subcell Biochem, vol.42, pp.3-27, 2007.
DOI : 10.1007/1-4020-5688-5_1

S. Antony, R. Kuttan, and G. Kuttan, Effect of viscum album in the inhibition of lung metastasis in mice induced by B16F10 melanoma cells, J Exp Clin Cancer Res, vol.16, pp.159-162, 1997.

S. Antony, R. Kuttan, and G. Kuttan, Role of Natural Killer Cells in Iscador Mediated Inhibition of Metastasis by Adoptive Immunotherapy, Immunological Investigations, vol.44, issue.3, pp.219-231, 2000.
DOI : 10.1042/bj1590457

R. Arens, Rational Design of Vaccines, Adv Immunol, vol.114, pp.217-243, 2012.
DOI : 10.1016/B978-0-12-396548-6.00009-3

F. Balkwill and A. Mantovani, Cancer and Inflammation: Implications for Pharmacology and Therapeutics, Clinical Pharmacology & Therapeutics, vol.71, issue.524, pp.401-406, 2010.
DOI : 10.1080/02841860903099964

F. Balkwill and A. Mantovani, Inflammation and cancer: back to Virchow?, The Lancet, vol.357, issue.9255, pp.539-545, 2001.
DOI : 10.1016/S0140-6736(00)04046-0

J. Banchereau and R. M. Steinman, Dendritic cells and the control of immunity, Nature, vol.392, issue.6673, pp.245-252, 1998.
DOI : 10.1038/32588

H. Bantel, I. H. Engels, W. Voelter, K. Schulze-osthoff, and S. Wesselborg, Mistletoe lectin activates caspase-8/FLICE independently of death receptor signaling and enhances anticancer drug-induced apoptosis, Cancer Res, vol.59, pp.2083-2090, 1999.

L. J. Bayne, G. L. Beatty, N. Jhala, C. E. Clark, A. D. Rhim et al., Tumor-Derived Granulocyte-Macrophage Colony-Stimulating Factor Regulates Myeloid Inflammation and T Cell Immunity in Pancreatic Cancer, Cancer Cell, vol.21, issue.6, pp.822-835, 2012.
DOI : 10.1016/j.ccr.2012.04.025

J. Bayry, N. Misra, V. Latry, F. Prost, S. Delignat et al., Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases, and the cell membrane permeabilizing viscotoxins, pp.165-169, 2003.
DOI : 10.1016/S1246-7820(03)00035-1

Y. Cai, Y. F. Lee, G. Li, S. Liu, B. Y. Bao et al., A new prostate cancer therapeutic approach: Combination of androgen ablation with COX-2 inhibitor, International Journal of Cancer, vol.119, issue.1, pp.195-201, 2008.
DOI : 10.1002/ijc.23481

P. Carmeliet, Mechanisms of angiogenesis and arteriogenesis, Nature Medicine, vol.6, issue.4, pp.389-395, 2000.
DOI : 10.1038/74651

C. Cerella, C. Sobolewski, M. Dicato, and M. Diederich, Targeting COX-2 expression by natural compounds: A promising alternative strategy to synthetic COX-2 inhibitors for cancer chemoprevention and therapy, Biochemical Pharmacology, vol.80, issue.12, pp.1801-1815, 2010.
DOI : 10.1016/j.bcp.2010.06.050

N. V. Chandrasekharan, H. Dai, K. L. Roos, N. K. Evanson, J. Tomsik et al., COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression, Proceedings of the National Academy of Sciences, vol.99, issue.21, pp.13926-13931, 2002.
DOI : 10.1073/pnas.162468699

O. Christen-clottu, P. Klocke, D. Burger, R. Straub, and V. Gerber, Treatment of Clinically Diagnosed Equine Sarcoid with a Mistletoe Extract (Viscum album austriacus), Journal of Veterinary Internal Medicine, vol.269, issue.(1), pp.1483-1489, 2010.
DOI : 10.1111/j.1939-1676.2010.0597.x

S. Chrubasik, O. Kunzel, A. Model, C. Conradt, and A. Black, Treatment of low back pain with a herbal or synthetic anti-rheumatic: a randomized controlled study. Willow bark extract for low back pain, Rheumatology, vol.40, issue.12, pp.1388-1393, 2001.
DOI : 10.1093/rheumatology/40.12.1388

R. Clark and T. Kupper, Old Meets New: The Interaction Between Innate and Adaptive Immunity, Journal of Investigative Dermatology, vol.125, issue.4, pp.629-637, 2005.
DOI : 10.1111/j.0022-202X.2005.23856.x

A. Coulon, A. Mosbah, A. Lopez, A. M. Sautereau, G. Schaller et al., Comparative membrane interaction study of viscotoxins A3, A2 and B from mistletoe (Viscum album) and connections with their structures, Biochemical Journal, vol.374, issue.1, pp.71-78, 2003.
DOI : 10.1042/bj20030488

L. J. Crofford, COX-1 and COX-2 tissue expression: implications and predictions, J Rheumatol, pp.15-19, 1997.

K. B. Cullberg, J. Olholm, S. K. Paulsen, C. B. Foldager, M. Lind et al., Resveratrol has inhibitory effects on the hypoxia-induced inflammation and angiogenesis in human adipose tissue in vitro, European Journal of Pharmaceutical Sciences, vol.49, issue.2, pp.251-257, 2013.
DOI : 10.1016/j.ejps.2013.02.014

T. J. Curiel, Tregs and rethinking cancer immunotherapy, Journal of Clinical Investigation, vol.117, issue.5, pp.1167-1174, 2007.
DOI : 10.1172/JCI31202

J. A. Didonato, F. Mercurio, K. , and M. , NF-??B and the link between inflammation and cancer, Immunological Reviews, vol.472, issue.Suppl, pp.379-400
DOI : 10.1111/j.1600-065X.2012.01099.x

A. Diefenbach, E. R. Jensen, A. M. Jamieson, R. , and D. H. , Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity, Nature, vol.413, issue.6852, pp.165-171, 2001.
DOI : 10.1038/35093109

C. G. Drake, E. Jaffee, and D. M. Pardoll, Mechanisms of Immune Evasion by Tumors, Adv Immunol, vol.90, pp.51-81, 2006.
DOI : 10.1016/S0065-2776(06)90002-9

G. P. Dunn, A. T. Bruce, H. Ikeda, L. J. Old, and R. D. Schreiber, Cancer immunoediting: from immunosurveillance to tumor escape, Nature Immunology, vol.3, issue.11, 2002.
DOI : 10.1038/ni1102-991

G. P. Dunn, L. J. Old, and R. D. Schreiber, The Three Es of Cancer Immunoediting, Annual Review of Immunology, vol.22, issue.1, pp.329-360, 2004.
DOI : 10.1146/annurev.immunol.22.012703.104803

J. H. Dunn, L. Z. Ellis, and M. Fujita, Inflammasomes as molecular mediators of inflammation and cancer: Potential role in melanoma, Cancer Letters, vol.314, issue.1, pp.24-33, 2011.
DOI : 10.1016/j.canlet.2011.10.001

D. Van-huyen, J. P. Bayry, J. Delignat, S. Gaston, A. T. Michel et al., Induction of apoptosis of endothelial cells by Viscum album: a role for antitumoral properties of mistletoe lectins, 2002.

D. Van-huyen, J. P. Delignat, S. Bayry, J. Kazatchkine, M. D. Bruneval et al., Interleukin-12 is associated with the in vivo anti-tumor effect of mistletoe extracts in B16 mouse melanoma, Cancer Letters, vol.243, issue.1, pp.32-37, 2006.
DOI : 10.1016/j.canlet.2005.11.016

D. Van-huyen, J. P. Delignat, S. Kazatchkine, M. D. Kaveri, and S. V. , Comparative Study of the Sensitivity of Lymphoblastoid and Transformed Monocytic Cell Lines to the Cytotoxic Effects of Viscum album Extracts of Different Origin, Chemotherapy, vol.49, issue.6, pp.298-302, 2003.
DOI : 10.1159/000074530

D. Van-huyen, J. P. Sooryanarayana, S. Delignat, M. F. Bloch, M. D. Kazatchkine et al., Variable sensitivity of lymphoblastoid cells to apoptosis induced by Viscum album Qu FrF, a therapeutic preparation of mistletoe lectin, Chemotherapy, vol.47, pp.366-376, 2001.

U. Edlund, A. Hensel, D. Frose, U. Pfuller, and A. Scheffler, Polysaccharides from Fresh Viscum album L. Berry Extract and Their Interaction with Viscum album Agglutinin I, Arzneimittelforschung, vol.50, issue.07, pp.645-651, 2000.
DOI : 10.1055/s-0031-1300265

T. Efferth and E. Koch, Complex Interactions between Phytochemicals. The Multi-Target Therapeutic Concept of Phytotherapy, Current Drug Targets, vol.12, issue.1, pp.122-132, 2010.
DOI : 10.2174/138945011793591626

S. Elluru, J. P. Duong-van-huyen, S. Delignat, F. Prost, J. Bayry et al., Molecular mechanisms underlying the immunomodulatory effects of mistletoe, 2006.

S. R. Elluru, J. P. Duong-van-huyen, S. Delignat, M. D. Kazatchkine, A. Friboulet et al., Induction of maturation and activation of human dendritic cells: A mechanism underlying the beneficial effect of Viscum albumas complimentary therapy in cancer, BMC Cancer, vol.210, issue.9, p.161, 2008.
DOI : 10.1016/j.imbio.2005.07.004

S. R. Elluru, J. P. Duong-van-huyen, S. Delignat, F. Prost, D. Heudes et al., Antiangiogenic properties of viscum album extracts are associated with endothelial cytotoxicity, Anticancer Res, vol.29, pp.2945-2950, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00409601

E. Ernst, The role of complementary and alternative medicine in cancer, The Lancet Oncology, vol.1, issue.3, pp.176-180, 2000.
DOI : 10.1016/S1470-2045(00)00031-0

J. Finke, S. Ferrone, A. Frey, A. Mufson, and A. Ochoa, Where have all the T cells gone? Mechanisms of immune evasion by tumors, Immunology Today, vol.20, issue.4, pp.158-160, 1999.
DOI : 10.1016/S0167-5699(98)01435-2

J. Folkman, Angiogenesis in cancer, vascular, rheumatoid and other disease, Nature Medicine, vol.326, issue.1, pp.27-31, 1995.
DOI : 10.1038/359845a0

H. Franz, [Ingredients of mistletoe (Viscum album L.) as potential drugs], Pharmazie, vol.40, pp.97-104, 1985.

H. Franz, A. Kindt, R. Eifler, P. Ziska, R. Benndorf et al., Differences in toxicity and antigenicity between mistletoe lectin I and viscotoxin A 3, Biomed Biochim Acta, vol.42, pp.21-25, 1983.

H. Franz, P. Ziska, and A. Kindt, L.), Biochemical Journal, vol.195, issue.2, pp.481-484, 1981.
DOI : 10.1042/bj1950481
URL : https://hal.archives-ouvertes.fr/in2p3-00023200

T. F. Gajewski, Y. Meng, H. , and H. , Immune Suppression in the Tumor Microenvironment, Journal of Immunotherapy, vol.29, issue.3, pp.233-240, 2006.
DOI : 10.1097/01.cji.0000199193.29048.56

J. G. Geng, Directional migration of leukocytes: their pathological roles in inflammation and strategies for development of anti-inflammatory therapies, Cell Research, vol.107, issue.2, pp.85-88, 2001.
DOI : 10.1006/smim.2000.0210

M. Girardi, D. E. Oppenheim, C. R. Steele, J. M. Lewis, E. Glusac et al., Regulation of Cutaneous Malignancy by gamma delta T Cells, Science, vol.294, issue.5542, pp.605-609, 2001.
DOI : 10.1126/science.1063916

A. Giulietti, E. Van-etten, L. Overbergh, K. Stoffels, R. Bouillon et al., Monocytes from type 2 diabetic patients have a pro-inflammatory profile, Diabetes Research and Clinical Practice, vol.77, issue.1, pp.47-57, 2007.
DOI : 10.1016/j.diabres.2006.10.007

A. Grakoui, S. K. Bromley, C. Sumen, M. M. Davis, A. S. Shaw et al., The Immunological Synapse: A Molecular Machine Controlling T Cell Activation, Science, vol.285, issue.5425, pp.221-227, 1999.
DOI : 10.1126/science.285.5425.221

T. Hagemann, F. Balkwill, L. , and T. , Inflammation and Cancer: A Double-Edged Sword, Cancer Cell, vol.12, issue.4, pp.300-301, 2007.
DOI : 10.1016/j.ccr.2007.10.005

W. C. Hahn and R. A. Weinberg, Modelling the molecular circuitry of cancer, Nature Reviews Cancer, vol.2, issue.5, pp.331-341, 2002.
DOI : 10.1038/nrc795

T. Hajto, Immunomodulatory Effects of Iscador: A Viscum album Preparation, Oncology, vol.43, issue.1, pp.51-65, 1986.
DOI : 10.1159/000226420

T. Hajto, K. Hostanska, J. Fischer, and R. Saller, Immunomodulatory effects of Viscum album agglutinin-l on natural immunity, Anti-Cancer Drugs, vol.8, issue.Supplement 1, pp.43-46, 1997.
DOI : 10.1097/00001813-199704001-00010

T. Hajto, K. Hostanska, and H. J. Gabius, Modulatory potency of the beta-galactoside-specific lectin from mistletoe extract (Iscador) on the host defense system in vivo in rabbits and patients, Cancer Res, vol.49, pp.4803-4808, 1989.

D. Hanahan and R. A. Weinberg, The Hallmarks of Cancer, Cell, vol.100, issue.1, pp.57-70, 2000.
DOI : 10.1016/S0092-8674(00)81683-9

A. A. Hurwitz and S. K. Watkins, Immune suppression in the tumor microenvironment: a role for dendritic cell-mediated tolerization of T cells, Cancer Immunology, Immunotherapy, vol.24, issue.2, pp.289-293, 2012.
DOI : 10.1007/s00262-011-1181-5

C. A. Janeway and . Jr, The immune system evolved to discriminate infectious nonself from noninfectious self, Immunology Today, vol.13, issue.1, pp.11-16, 1992.
DOI : 10.1016/0167-5699(92)90198-G

C. A. Janeway, . Jr, and R. Medzhitov, Introduction: The role of innate immunity in the adaptive immune response, Seminars in Immunology, vol.10, issue.5, pp.349-350, 1998.
DOI : 10.1006/smim.1998.0142

E. Jordan and H. Wagner, Structure and Properties of Polysaccharides from Viscum album (L.), Oncology, vol.43, issue.1, pp.8-15, 1986.
DOI : 10.1159/000226414

J. S. Jurenka, Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research, Altern Med Rev, vol.14, pp.141-153, 2009.

M. Jurin, N. Zarkovic, M. Hrzenjak, and Z. Ilic, Antitumorous and Immunomodulatory Effects of the Viscum album L. Preparation Isorel, Oncology, vol.50, issue.6, pp.393-398, 1993.
DOI : 10.1159/000227217

E. Kaegi, Unconventional therapies for cancer: 3. Iscador. Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative, CMAJ, vol.158, pp.1157-1159, 1998.

P. C. Kam and A. U. See, Cyclo-oxygenase isoenzymes: physiological and pharmacological role, Anaesthesia, vol.93, issue.(Suppl. 9), pp.442-449, 2000.
DOI : 10.1046/j.1365-2044.2000.01271.x

M. Karin and F. R. Greten, NF-??B: linking inflammation and immunity to cancer development and progression, Nature Reviews Immunology, vol.100, issue.10, pp.749-759, 2005.
DOI : 10.1038/nri1703

M. Karin, T. Lawrence, and V. Nizet, Innate Immunity Gone Awry: Linking Microbial Infections to Chronic Inflammation and Cancer, Cell, vol.124, issue.4, pp.823-835, 2006.
DOI : 10.1016/j.cell.2006.02.016

R. S. Kerbel, Antiangiogenic Therapy: A Universal Chemosensitization Strategy for Cancer?, Science, vol.312, issue.5777, pp.1171-1175, 2006.
DOI : 10.1126/science.1125950

N. Khan, F. Afaq, M. H. Kweon, K. Kim, and H. Mukhtar, Oral Consumption of Pomegranate Fruit Extract Inhibits Growth and Progression of Primary Lung Tumors in Mice, Cancer Research, vol.67, issue.7, pp.3475-3482, 2007.
DOI : 10.1158/0008-5472.CAN-06-3941

G. S. Kienle and H. Kiene, Review Article: Influence of Viscum album L (European Mistletoe) Extracts on Quality of Life in Cancer Patients: A Systematic Review of Controlled Clinical Studies, Integrative Cancer Therapies, vol.2, issue.1, pp.142-157, 2010.
DOI : 10.1177/1534735410369673

B. Kis, J. A. Snipes, T. Isse, K. Nagy, and D. W. Busija, Putative Cyclooxygenase-3 Expression in Rat Brain Cells, Journal of Cerebral Blood Flow & Metabolism, vol.361, pp.1287-1292, 2003.
DOI : 10.1097/01.WCB.0000090681.07515.81

J. Konopa, J. M. Woynarowski, and M. Lewandowska-gumieniak, L., Hoppe-Seyler??s Zeitschrift f??r physiologische Chemie, vol.361, issue.2, pp.1525-1533, 1980.
DOI : 10.1515/bchm2.1980.361.2.1525

J. K. Kundu and Y. J. Surh, Emerging avenues linking inflammation and cancer, Free Radical Biology and Medicine, vol.52, issue.9, pp.2013-2037, 2012.
DOI : 10.1016/j.freeradbiomed.2012.02.035

G. Kuttan and R. Kuttan, Extract (NSC 635 089), Immunological Investigations, vol.44, issue.4, pp.285-296, 1992.
DOI : 10.3109/08820139209069368

G. Kuttan, D. M. Vasudevan, and R. Kuttan, Effect of a preparation from Viscum album on tumor development A cytokine-mediated link between innate immunity, inflammation, and cancer, J Clin Invest, vol.117, pp.1175-1183, 1990.

M. Liu, Transfected human dendritic cells as cancer vaccines, Nature Biotechnology, vol.264, issue.4, pp.335-336, 1998.
DOI : 10.1146/annurev.immunol.15.1.617

S. Y. Lyu and W. B. Park, Effects of Korean Mistletoe Lectin(Viscum album coloratum) on Proliferation and Cytokine Expression in Human Peripheral Blood Mononuclear Cells and T-Lymphocytes, Archives of Pharmacal Research, vol.1551, issue.1, pp.1252-1264, 2007.
DOI : 10.1007/BF02980266

A. Mantovani, P. Allavena, A. Sica, and F. Balkwill, Cancer-related inflammation, Nature, vol.342, issue.7203, pp.436-444, 2008.
DOI : 10.1038/nature07205

L. J. Marnett, The COXIB Experience: A Look in the Rearview Mirror, Annual Review of Pharmacology and Toxicology, vol.49, issue.1, pp.265-290, 2009.
DOI : 10.1146/annurev.pharmtox.011008.145638

J. Martel-pelletier, J. P. Pelletier, and H. Fahmi, Cyclooxygenase-2 and prostaglandins in articular tissues, Seminars in Arthritis and Rheumatism, vol.33, issue.3, pp.155-167, 2003.
DOI : 10.1016/S0049-0172(03)00134-3

P. Matzinger, Tolerance, Danger, and the Extended Family, Annual Review of Immunology, vol.12, issue.1, pp.991-1045, 1994.
DOI : 10.1146/annurev.iy.12.040194.005015

R. Medzhitov, Inflammation 2010: New Adventures of an Old Flame, Cell, vol.140, issue.6, pp.771-776
DOI : 10.1016/j.cell.2010.03.006

R. Medzhitov, Origin and physiological roles of inflammation, Nature, vol.21, issue.7203, pp.428-435, 2008.
DOI : 10.1038/nature07201

R. Medzhitov, C. Janeway, and . Jr, Innate immunity, Current Opinion in Immunology, vol.15, issue.1, pp.338-344, 2000.
DOI : 10.1016/S0952-7915(02)00019-5
URL : https://hal.archives-ouvertes.fr/hal-01438527

R. Medzhitov, C. A. Janeway, and . Jr, Innate immunity: impact on the adaptive immune response, Current Opinion in Immunology, vol.9, issue.1, pp.4-9, 1997.
DOI : 10.1016/S0952-7915(97)80152-5

S. Miller, J. Stagl, D. B. Wallerstedt, M. Ryan, and P. J. Mansky, Botanicals used in complementary and alternative medicine treatment of cancer: clinical science and future perspectives, Expert Opinion on Investigational Drugs, vol.119, issue.9, pp.1353-1364, 2008.
DOI : 10.1200/JCO.2005.10.728

R. A. Morgan, M. E. Dudley, J. R. Wunderlich, M. S. Hughes, J. C. Yang et al., Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes, Science, vol.314, issue.5796, pp.126-129, 2006.
DOI : 10.1126/science.1129003

M. D. Mossalayi, A. Alkharrat, and D. Malvy, Nitric Oxide Involvement in the Anti-tumor Effect of Mistletoe (Viscum album L.) Extracts Iscador on Human Macrophages, Arzneimittelforschung, vol.56, issue.06, pp.457-460, 2006.
DOI : 10.1055/s-0031-1296812

F. O. Nestle, J. Banchereau, H. , and D. , Dendritic cells: On the move from bench to bedside, Nature Medicine, vol.7, issue.7, pp.761-765, 2001.
DOI : 10.1038/89863

N. X. Nhiem, P. V. Kiem, C. V. Minh, N. Kim, S. Park et al., Diarylheptanoids and Flavonoids from Viscum album Inhibit LPS-Stimulated Production of Pro-inflammatory Cytokines in Bone Marrow-Derived Dendritic Cells, J Nat Prod, 2013.

D. D. Orhan, E. Kupeli, E. Yesilada, and F. Ergun, Abstract, Zeitschrift f??r Naturforschung C, vol.61, issue.1-2, pp.26-30, 2006.
DOI : 10.1515/znc-2006-1-205

D. Pardoll, ?, Annual Review of Immunology, vol.21, issue.1, pp.807-839, 2003.
DOI : 10.1146/annurev.immunol.21.120601.141135

D. M. Pardoll, Cancer vaccines, Nature Medicine, vol.271, issue.5s, pp.525-531, 1998.
DOI : 10.1073/pnas.94.15.8099

L. M. Parente, S. Lino-junior-rde, L. M. Tresvenzol, M. C. Vinaud, J. R. De-paula et al., Wound Healing and Anti- Inflammatory Effect in Animal Models of Calendula officinalis L. Growing in Brazil. Evid Based Complement Alternat Med Inhibition of tumor growth and metastasis by Korean mistletoe lectin is associated with apoptosis and antiangiogenesis, Cancer Biother Radiopharm, vol.375671, issue.16, pp.439-447, 2001.

M. Pelletier, V. Lavastre, A. Savoie, C. Ratthe, R. Saller et al., Modulation of Interleukin-15-Induced Human Neutrophil Responses by the Plant Lectin Viscum album Agglutinin-I, Clinical Immunology, vol.101, issue.2, pp.229-236, 2001.
DOI : 10.1006/clim.2001.5105

I. F. Pryme, S. Bardocz, A. Pusztai, and S. W. Ewen, Dietary mistletoe lectin supplementation and reduced growth of a murine non-Hodgkin lymphoma, Histol Histopathol, vol.17, pp.261-271, 2002.

K. Raina, R. P. Singh, R. Agarwal, and C. Agarwal, Oral Grape Seed Extract Inhibits Prostate Tumor Growth and Progression in TRAMP Mice, Cancer Research, vol.67, issue.12, pp.5976-5982, 2007.
DOI : 10.1158/0008-5472.CAN-07-0295

P. Rao and E. E. Knaus, Evolution of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Cyclooxygenase (COX) Inhibition and Beyond, Journal of Pharmacy & Pharmaceutical Sciences, vol.11, issue.2, pp.81-110, 2008.
DOI : 10.18433/J3T886

G. Ribereau-gayon, M. L. Jung, S. Baudino, G. Salle, and J. P. Beck, Effects of mistletoe (Viscum album L.) extracts on cultured tumor cells, Experientia, vol.5, issue.6, pp.594-599, 1986.
DOI : 10.1007/BF01955552

S. A. Rosenberg, P. Spiess, and R. Lafreniere, A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes, Science, vol.233, issue.4770, pp.1318-1321, 1986.
DOI : 10.1126/science.3489291

C. A. Rouzer and L. J. Marnett, Cyclooxygenases: structural and functional insights, The Journal of Lipid Research, vol.50, issue.Supplement, 2009.
DOI : 10.1194/jlr.R800042-JLR200
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2674713

U. Schumacher, A. Stamouli, E. Adam, M. Peddie, and U. Pfuller, Biochemical, histochemical and cell biological investigations on the actions of mistletoe lectins I, II and III with human breast cancer cell lines, Glycoconjugate Journal, vol.142, issue.3, pp.250-257, 1995.
DOI : 10.1007/BF00731327

C. Servais and N. Erez, From sentinel cells to inflammatory culprits: cancer-associated fibroblasts in tumour-related inflammation, The Journal of Pathology, vol.6, issue.2, pp.198-207, 2012.
DOI : 10.1002/path.4103

G. Sethi, M. K. Shanmugam, L. Ramachandran, A. P. Kumar, and V. Tergaonkar, Multifaceted link between cancer and inflammation, Bioscience Reports, vol.62, issue.1, pp.1-15, 2011.
DOI : 10.1093/carcin/bgi012

C. Sharma, J. Kaur, S. Shishodia, B. B. Aggarwal, and R. And-ralhan, Curcumin down regulates smokeless tobacco-induced NF-??B activation and COX-2 expression in human oral premalignant and cancer cells, Toxicology, vol.228, issue.1, pp.1-15, 2006.
DOI : 10.1016/j.tox.2006.07.027

D. A. Shoskes, Phytotherapy in chronic prostatitis, Urology, vol.60, issue.6, pp.35-37, 2002.
DOI : 10.1016/S0090-4295(02)02383-X

A. Slusarz, N. S. Shenouda, M. S. Sakla, S. K. Drenkhahn, A. S. Narula et al., Common Botanical Compounds Inhibit the Hedgehog Signaling Pathway in Prostate Cancer, Cancer Research, vol.70, issue.8, pp.3382-3390, 2010.
DOI : 10.1158/0008-5472.CAN-09-3012

G. M. Stein, U. Edlund, U. Pfuller, A. Bussing, and M. Schietzel, Influence of polysaccharides from Viscum album L. on human lymphocytes, monocytes and granulocytes in vitro, Anticancer Res, vol.19, pp.3907-3914, 1999.

G. M. Stein, G. Schaller, U. Pfuller, M. Schietzel, and A. Bussing, Thionins from Viscum album L: influence of the viscotoxins on the activation of granulocytes, Anticancer Res, vol.19, pp.1037-1042, 1999.

F. Stirpe, R. F. Legg, L. J. Onyon, P. Ziska, F. et al., Inhibition of protein synthesis by a toxic lectin from Viscum album L. (mistletoe), 1980.

Y. J. Surh and J. K. Kundu, Signal transduction network leading to COX-2 Induction: a road map in search of cancer chemopreventives, Archives of Pharmacal Research, vol.62, issue.2, pp.1-15, 2005.
DOI : 10.1007/BF02975128

J. Tabiasco, F. Pont, J. J. Fournie, and A. Vercellone, Mistletoe viscotoxins increase natural killer cell-mediated cytotoxicity, European Journal of Biochemistry, vol.83, issue.Suppl. 1, pp.2591-2600, 2002.
DOI : 10.1046/j.1432-1033.2002.02932.x

E. Talero, J. Avila-roman, and V. Motilva, Chemoprevention with Phytonutrients and Microalgae Products in Chronic Inflammation and Colon Cancer, Current Pharmaceutical Design, vol.18, issue.26, pp.3939-3965, 2012.
DOI : 10.2174/138161212802083725

T. T. Tan, C. , and L. M. , Humoral immunity, inflammation and cancer, Current Opinion in Immunology, vol.19, issue.2, pp.209-216, 2007.
DOI : 10.1016/j.coi.2007.01.001

U. Valentiner, U. Pfuller, C. Baum, and U. Schumacher, The cytotoxic effect of mistletoe lectins I, II and III on sensitive and multidrug resistant human colon cancer cell lines in vitro, Toxicology, vol.171, issue.2-3, pp.187-199, 2002.
DOI : 10.1016/S0300-483X(01)00581-9

D. B. Vendramini-costa and J. E. Carvalho, Molecular Link Mechanisms between Inflammation and Cancer, Current Pharmaceutical Design, vol.18, issue.26, pp.3831-3852, 2012.
DOI : 10.2174/138161212802083707

M. D. Vesely, M. H. Kershaw, R. D. Schreiber, and M. J. Smyth, Natural Innate and Adaptive Immunity to Cancer, Annual Review of Immunology, vol.29, issue.1, pp.235-271, 2011.
DOI : 10.1146/annurev-immunol-031210-101324

J. Wang and Y. F. Zhu, [Extraction and content determination of polysaccharides in Viscum coloratum], Zhongguo Zhong Yao Za Zhi, vol.32, pp.2387-2390, 2007.

D. R. Yance, . Jr, and S. M. Sagar, Targeting Angiogenesis With Integrative Cancer Therapies, Integrative Cancer Therapies, vol.19, issue.11, pp.9-29, 2006.
DOI : 10.1177/1534735405285562

W. Ye, R. P. Nanga, C. B. Kang, J. H. Song, S. K. Song et al., Molecular characterization of the recombinant A-chain of a type II ribosome-inactivating protein (RIP) from Viscum album coloratum and structural basis on its ribosomeinactivating activity and the sugarbinding properties of the B-chain, J Biochem Mol Biol, vol.39, pp.560-570, 2006.

T. J. Yoon, Y. C. Yoo, O. B. Choi, M. S. Do, T. B. Kang et al., Inhibitory effect of Korean mistletoe (Viscum album coloratum) extract on tumour angiogenesis and metastasis of haematogenous and non-haematogenous tumour cells in mice, Cancer Letters, vol.97, issue.1, pp.83-91, 1995.
DOI : 10.1016/0304-3835(95)03956-W

T. J. Yoon, Y. C. Yoo, T. B. Kang, S. K. Song, K. B. Lee et al., Antitumor activity of the Korean Mistletoe Lectin is attributed to activation of macrophages and NK cells, Archives of Pharmacal Research, vol.1, issue.suppl. 1, pp.861-867, 2003.
DOI : 10.1007/BF02980033

H. Yu, D. Pardoll, J. , and R. , STATs in cancer inflammation and immunity: a leading role for STAT3, Nature Reviews Cancer, vol.277, issue.11, pp.798-809, 2009.
DOI : 10.1038/nrc2734

B. Zafirova, F. M. Wensveen, M. Gulin, and B. Polic, Regulation of immune cell function and differentiation by the NKG2D receptor, Cellular and Molecular Life Sciences, vol.31, issue.21, pp.3519-3529, 2011.
DOI : 10.1007/s00018-011-0797-0

D. Y. Zhang, J. Wu, F. Ye, L. Xue, S. Jiang et al., Inhibition of cancer cell proliferation and prostaglandin E2 synthesis by Scutellaria baicalensis, Cancer Res, vol.63, pp.4037-4043, 2003.

L. Zhang, A. M. Bertucci, K. A. Smith, L. Xu, and S. K. Datta, Hyperexpression of cyclooxygenase 2 in the lupus immune system and effect of cyclooxygenase 2 inhibitor diet therapy in a murine model of systemic lupus erythematosus, Arthritis & Rheumatism, vol.173, issue.12, pp.4132-4141, 2007.
DOI : 10.1002/art.23054

L. Zitvogel, A. Tesniere, and G. Kroemer, Cancer despite immunosurveillance: immunoselection and immunosubversion, Nature Reviews Immunology, vol.65, issue.10, pp.715-727, 2006.
DOI : 10.1038/nri1936

W. Zou, Immunosuppressive networks in the tumour environment and their therapeutic relevance, Nature Reviews Cancer, vol.1, issue.4, pp.263-274, 2005.
DOI : 10.1073/pnas.96.26.15074

M. S. Maddur, S. Othy, P. Hegde, J. Vani, S. Lacroix-desmazes et al., Immunomodulation by Intravenous Immunoglobulin: Role of Regulatory T Cells, Journal of Clinical Immunology, vol.112, issue.S1, pp.4-8, 2010.
DOI : 10.1007/s10875-010-9394-5

P. Hegde, M. Maddur, A. Friboulet, J. Bayry, and S. Kaveri, Viscum album Exerts Anti-Inflammatory Effect by Selectively Inhibiting Cytokine-Induced Expression of Cyclooxygenase-2, PLoS ONE, vol.35, issue.10, p.26312, 2011.
DOI : 10.1371/journal.pone.0026312.t001
URL : https://hal.archives-ouvertes.fr/hal-00637405

S. Kaveri, M. Maddur, P. Hegde, S. Lacroix-desmazes, and J. Bayry, Intravenous immunoglobulins in immunodeficiencies: more than mere replacement therapy, Clinical & Experimental Immunology, vol.36, issue.10, pp.2-5, 2011.
DOI : 10.1111/j.1365-2249.2011.04387.x

M. Maddur, P. Hegde, M. Sharma, S. Kaveri, and J. Bayry, B cells are resistant to immunomodulation by ???IVIg-educated??? dendritic cells, Autoimmunity Reviews, vol.11, issue.2, pp.154-156, 2011.
DOI : 10.1016/j.autrev.2011.08.004

M. Maddur, J. Vani, P. Hegde, S. Lacroix-desmazes, and S. Kaveri, Inhibition of differentiation, amplification, and function of human TH17 cells by intravenous immunoglobulin, Journal of Allergy and Clinical Immunology, vol.127, issue.3, pp.823-830, 2011.
DOI : 10.1016/j.jaci.2010.12.1102

P. Hegde and S. Kaveri, Toll-like receptor-2 ligand lipomannan from Mycobacterium tuberculosis does not stimulate inflammatory cytokines in dendritic cells, AIDS, vol.26, issue.9, pp.1182-1184
DOI : 10.1097/QAD.0b013e3283543da4

M. Maddur, M. Sharma, P. Hegde, S. Lacroix-desmazes, and S. Kaveri, Inhibitory Effect of IVIG on IL-17 Production by Th17 Cells is Independent of Anti-IL-17 Antibodies in the Immunoglobulin Preparations, Journal of Clinical Immunology, vol.129, issue.Suppl 1, pp.62-66, 2013.
DOI : 10.1007/s10875-012-9752-6

S. Othy, P. Hegde, S. Topcu, M. Sharma, and M. Maddur, Intravenous Gammaglobulin Inhibits Encephalitogenic Potential of Pathogenic T Cells and Interferes with their Trafficking to the Central Nervous System, Implicating Sphingosine-1 Phosphate Receptor 1-Mammalian Target of Rapamycin Axis, The Journal of Immunology, vol.190, issue.9, pp.4535-4541, 2013.
DOI : 10.4049/jimmunol.1201965

M. Sharma, P. Hegde, V. Aimanianda, R. Beau, and H. Senechal, Circulating human basophils lack the features of professional antigen presenting cells, Sci Rep, vol.3, p.1188, 2013.

J. Trinath, P. Hegde, K. Balaji, S. Kaveri, and J. Bayry, Intravenous immunoglobulin-mediated regulation of Notch ligands on human dendritic cells, Journal of Allergy and Clinical Immunology, vol.131, issue.4, pp.1255-1257, 2013.
DOI : 10.1016/j.jaci.2013.01.031

J. Trinath, P. Hegde, M. Sharma, M. Maddur, and M. Rabin, Intravenous immunoglobulin expands regulatory T cells via induction of cyclooxygenase-2-dependent prostaglandin E2 in human dendritic cells, Blood, vol.122, issue.8, 2013.
DOI : 10.1182/blood-2012-11-468264

D. Alsteens, V. Aimanianda, P. Hegde, S. Pire, and R. Beau, Unraveling the Nanoscale Surface Properties of Chitin Synthase Mutants of??Aspergillus fumigatus and Their Biological Implications, Biophysical Journal, vol.105, issue.2, pp.320-327, 2013.
DOI : 10.1016/j.bpj.2013.05.040

P. Hegde, A. Friboulet, J. Bayry, and S. V. Kaveri, Viscum album-mediated PGE2 and COX-2 inhibition implicates COX-2 mRNA destabilisation

P. Hegde, A. Friboulet, J. Bayry, and S. Kaveri, Comparative analysis of anti-inflammatory properties of different Viscum album preparations: mistletoe lectin as a key molecule responsible for COX-2 inhibition